| Iliac Crest |
Moroder
(2019)[@140568] |
I |
Autograft
(vs. Latarjet) |
30 |
29 ± 9 (18-57) |
28/30 (93.3%) |
N/A |
24 months exactly |
13/30 (43.3%) |
19 ± 19 (3-80) (instability episodes) |
|
Ortmaier
(2019)[@140569] |
IV |
J-bone Autograft |
34 |
26.9 ± 12.3 |
29/34 (85.3%) |
N/A |
39.5 ± 9.6 months (25 to 56) |
20/34 (58.8%) |
15.9 ± 19.8 dislocations (1 to >100) |
|
Abdelshahed
(2018)[@140572] |
IV |
Cryopreserved Tri-cortical Iliac Crest Allograft |
10 |
30.0 |
9/10 (90.0%) |
N/A |
4.5 years ± 2.5 (2.3–9.1) |
0/14 (0.0%) |
NR |
|
Moroder
(2018 AJSM)[@140555] |
IV |
J-bone Autograft |
34 (35 shoulders) |
30 ± 10 (19-54) |
30/34 (88.2%) |
N/A |
8 years (15-23) |
16/35 (45.7%) |
13 (1- 50) |
|
Steffen
(2013)[@140570] |
IV |
Autograft
(interposition of the labrum on the burred surface of the graft and capsular re-tensioning) |
43 |
25 (17-35) |
40/43 (93.0%) |
Age <35 |
9.2 years (5-19) |
28/48 (58.3%) |
>30, 11 patients
13 (2-30), all other patients |
|
Auffarth
(2011)[@140571] |
IV |
J-bone Autograft |
47 |
NR |
NR |
N/A |
90 months (23-152) |
NR |
NR |
|
| Tibia |
Robinson
(2021)[@140576] |
IV |
Distal tibia Allograft |
12 |
26 ± 5.5 |
10/12 (83.3%) |
N/A |
28 months ± 7.4 (16-40) |
NR |
NR |
|
Provencher
(2019)[@140573] |
IV |
Distal Tibia Allograft |
31 |
25.5 (19-38) |
31/31 (100%) |
Prior failed Latarjet |
47 months (36-60) |
31/31 (100.0%) |
NR |
|
Frank
(2018)[@140574] |
III |
Distal Tibia Allograft
(vs. Latarjet) |
50 |
25.82 ± 5.90 |
48/50 (96.0%) |
Bone loss >25% or failed Latarjet |
46 months ±17 |
32/50 (64.0%) |
NR |
|
| Provencher (2017)[@140575] |
IV |
Distal Tibia Allograft |
27 |
31 ±5 |
27/27 (100%) |
N/A |
45 months (30-66) |
5/27 (18.5%) |
NR |
|
| Coracoid |
Belangero
(2021)[@140617] |
III |
Latarjet
(vs. Bristow) |
37 (41 shoulders) |
26.4 (16-46) |
37/41 (89.75%) |
High-demand sports participation |
60 months |
0/41 (0.0%) |
NR |
|
Chillemi
(2021)[@140603] |
IV |
Latarjet |
40 |
26.5 (18-35) |
33/40 (82.5%) |
N/A |
25.6 years (24-29) |
0/40 (0.0%) |
5 (2-14) |
|
Marjanovic
(2021)[@140616] |
IV |
Latarjet |
139 (140 shoulders) |
29.5 |
123/139 (88.5%) |
N/A |
110 months (8-174) |
32/140 (22.8%) |
NR |
|
Rai
(2021)[@140608] |
III |
Latarjet
(vs. arthroscopic Bankart) |
40 |
27.10 ± 7.00 (18-68) |
32/40 (80.0%) |
N/A |
35.8 months ± 7.47 (24-53) |
0/40 (0%) |
10.9 ± 4.0 (5–23) |
|
Sinha
(2021)[@140646] |
IV |
Latarjet |
49 |
27 (17–45) |
47/49 (95.9%) |
N/A |
2 years |
NR |
median, 11 (5-50) |
|
Thon
(2021)[@140578] |
III |
Latarjet
(seizure disorder vs. no seizure disorder) |
9 (10 shoulders) |
29.2 (20-37) |
8/9 (88.9%) |
Seizure disorder |
3.4 years (2.2-4.8) |
0/9 (0%) |
>5 dislocations: 7/9 (7.8%) |
|
| 44 |
30.3 (18-53) |
38/44 (86.4%) |
No seizure disorder |
3.8 years (2.1-5.6) |
0/44 (0%) |
>5 dislocations: 30/44 (68.2%) |
|
Ali
(2020)[@140610] |
III |
Latarjet |
15 |
28 ± 10 (23-34) |
12/15 (80.0%) |
N/A |
30.5 months (24-45) |
0/15 (0.0%) |
NR |
|
Cohen
(2020)[@140585] |
IV |
Latarjet
(no or minor bone resorption vs.major or total bone resorption) |
27 shoulders |
32 |
32/37 (86.5%) |
No or minor bone resorption |
27.9 months (12-67) |
NR |
NR |
|
| 11 shoulders |
35.8 |
Major or total bone resorption |
26.9 months (12-72) |
|
Di Giacomo
(2020)[@140650] |
IV |
Latarjet |
344
(358 shoulders) |
30.6 (16-68) |
287/344 (83.4%) |
N/A |
75 months (61-89) |
0/358 (0.0%) |
5.5 ± 4.6
(2-50) |
|
Domos
(2020)[@140581] |
IV |
Latarjet |
45 |
15.7 (13-17) |
26/45 (57.8%) |
Age <17 years |
6.6 years (3-26) |
0/45 (0.0%) |
median 2 (2- 22) |
|
Elamo
(2020)[@140595] |
III |
Latarjet
(vs. arthroscopic Bankart repair) |
15 |
32.4 |
13/15 (86.7%) |
Previous failed arthroscopic Bankart |
3.5 years (minimum 1 year) |
18/18 (100%) |
NR |
|
Maman
(2020)[@140652] |
III |
Latarjet
(vs. arthroscopic Bankart) |
27 |
29.2 (19-40) |
25/27 (92.5%) |
Age ≤40 years |
97 months (60-154) |
0/27 (0%) |
NR |
|
Rossi
(2020)[@140618] |
III |
Latarjet
(classic vs. congruent arc) |
66 |
24.9 (18-44) |
62/66 (93.9%) |
Athletes/classic arc Latarjet |
35.82 months (25-48) |
0/66 (0%) |
NR |
|
| 79 |
25.7 (18-45) |
73/79 (92.4%) |
Athletes/ congruent arc Latarjet |
46.02 months (24-90) |
0/73 (0%) |
NR |
|
Werthel
(2020)[@140591] |
III |
Latarjet
(primary vs. revision) |
20 |
28.9 ± 9.7 |
15/20 (75.0%) |
Primary surgery |
3.6 years ± 0.9 |
20/20 (100%) |
8.0 ± 11.4 |
|
| 216 |
27.7 ± 9.2 |
186/216 (86.1) |
Revision surgery |
3.4 years ± 0.8 |
0/216 (0%) |
6.2 ± 10.0 |
|
Yapp
(2020)[@140593] |
III |
Latarjet
(primary vs. revision) |
145 |
27.9a |
133/145 (91.7%) |
Primary surgery |
5.6 years (2–11)a |
0/145 (0.0%) |
5 (2-31)a |
|
| 60 |
54/60 (90.0%) |
Revision surgery |
60/60 (100%) |
|
De Carli
(2019)[@140657] |
III |
Bristow-Latarjet
(vs. open capsuloplasty) |
40 |
28 (16–41) |
24/40 (60.0%) |
Athletes |
6 years (6–9) |
0/40 (0.0%) |
NR |
|
Ernstbrunner
(2019)[@140582] |
IV |
Latarjet |
39 |
48 (40-66) |
|
Age ≥40 years |
11.0 years (8-16) |
15/40 (37.5%) |
17 (2-90) |
|
Flinkkilä
(2019)[@140592] |
III |
Latarjet
(primary vs. revision) |
47 |
32 ±14 |
36/47 (76.6%) |
Primary surgery |
3.8 years ± 2.3a (1-11) |
0/55 (0.0%) |
NR |
|
| 52 |
33 ± 8 |
42/52 (80.8%) |
Revision surgery |
3.8 years ± 2.3a |
57/57 (100.0%) |
|
Minkus
(2019)[@140597] |
IV |
Latarjet |
38 |
27 (18–48) |
34/38 (89.5%) |
N/A |
27 months (18–42) |
38/38 (100.0%) |
13 (2–60) |
|
Moroder
(2019)[@140568] |
I |
Latarjet |
30 |
31 ± 8 (18-47) |
28/30 (93.3%) |
N/A |
24 months |
15/30 (50.0%) |
16 ± 18 (2-80) |
|
Xu
(2019)[@140661] |
III |
Latarjet
(vs. arthroscopic Bankart vs. capsular shift) |
52 |
31.23 ± 6.12 |
34/52 (67.3%) |
Higher sports requirement |
67.6 months (range 60–72)a |
NR |
NR |
|
Bah
(2018)[@140586] |
III |
Latarjet
(vs. arthroscopic Bankart) |
43 |
24.25 ± 6.45 (16-37) |
7/43 (16.3%) |
N/A |
47.3 months ± 9.07 (24-67) |
0/43 (0.0%) |
10 ± 3.5 (2-19) |
|
Baverel
(2018)[@140663] |
III |
Latarjet
(competitive athletes) |
57 |
21.7 (16-29.7) |
51/57 (89.4%) |
Professional athletes aged 16-30 |
44 months (28-86) |
0/57 (0.0%) |
3 (1-7) |
|
Latarjet
(recreational athletes) |
49 |
22.5 (16-29.3) |
37/49 (75.5%) |
Recreational athletes aged 16-30 |
49 months (25-83) |
0/49 (0.0%) |
2.8 (1-6) |
|
de l’Escalopier
(2018)[@140580] |
IV |
Latarjet |
20 |
26.5 ± 8 years |
NR |
Soldiers |
16.3 years (15-24 years) |
NR |
NR |
|
Erşen
(2018 KSSTA)[@140666] |
III |
Latarjet
(subscapularis tenotomy group vs. subscapularis split) |
20 (36 shoulders) |
33.2 |
18/20 (90%) |
Subscapularis tenotomy |
39 months |
4/20 (20%) |
10.3 |
|
| 28 (37 shoulders) |
33.9 |
24/28 (85.7%) |
Subscapularis split |
19 months |
4/28 (14.3%) r |
12.6 |
|
Frank
(2018)[@140574] |
III |
Latarjet
(vs. Tibia Allograft) |
50 |
25.40 ± 6.29 |
70/73 (95.9%) |
N/A |
46 months ±17 |
32/50 (64.0%) |
NR |
|
Jeon
(2018)[@140613] |
III |
Latarjet
(vs. arthroscopic Bankart) |
31 |
27.4 ± 5.0 |
26/31 (83.9%) |
N/A |
30.9 ± 10.9 months |
0/31 (0.0%) |
10.8 ± 5.8 |
|
Kawasaki
(2018)[@140589] |
IV |
Bristow |
152 (176 shoulders) |
18.9 (18.3-19.4) |
152/152 (100%) |
Rugby players |
51.5 months (47.3-55.6) |
NR |
2.2 (1.7-2.6) (prior subluxation: 11.5 [8.6-14.5]) |
|
Kee
(2018)[@140669] |
III |
Latarjet
(collision vs. non-collision athletes) |
27 |
25.6 ± 6.2 |
54/56 (96.4%)a |
Non-collision athletes |
66.3 months ± 25.1 |
18/27 (66.7%) |
NR |
|
| 29 |
28.9 ± 5.2 |
Collision athletes |
67.8 months ± 26.0 |
24/29 (82.8%) |
|
Lateur
(2018)[@140604] |
IV |
Latarjet
(mini-invasive approach: skin incision 3-6 cm long allowing bony block to be passed under subscapularis tendon w/out sectioning it and to be placed in lying position) |
32 |
34.5 ± 9 (21-60) |
32/38 (84.2%) |
N/A |
48 months ± 18 (24–84) |
NR |
6.6 (1-20) |
|
Moroder
(2018 JSES)[@140555] |
IV |
Latarjet or Bristow |
29 |
62 (40-85) |
13/25 (52.0%) |
Age >40 years |
9 years (2-15) |
6/27 (22.2%) |
15 (2- approximately 100) |
|
Privitera
(2018)[@140619] |
IV |
Latarjet |
73 |
25.8 (15-54) |
64/73 (87.7%) |
Contact and collision sports athletes |
52 months (24-120) |
43/73
(58.9%) |
NR |
|
Ranalletta
(2018 JARS)[@140598] |
IV |
Modified Latarjet
(no capsulolabral repair) |
65 |
26.8 (17-35) |
63/65 (96.9%) |
Athletes |
44 months (24-108) |
68/68 (100.0%) |
NR |
|
Ranalletta
(2018 AJSM)[@140598] |
IV |
Modified Latarjet
(no capsulolabral repair) |
49 |
22.8 (17-35) |
48/49 (98.0%) |
Competitive rugby players |
48 months (24-108) |
31/49 |
NR |
|
Rossi
(2018)[@140674] |
III |
Modified Latarjet
(primary vs. revision surgery) |
100 |
25.7 (17-46) |
40/46 (87.0%) |
Competitive athletes/Primary surgery |
58 months (24-108) |
0/46 (0%) |
NR |
|
| 27.3 (17-50) |
52/54 (96.3%) |
Competitive athletes/Revision surgery |
54/54 (100.0%) |
NR |
|
Yang
(2018)[@140605] |
III |
Modified Latarjet
(vs. remplissage w/ 3 subgroup analyses) |
91 |
30 ±12.1 |
86/91 (94.5%) |
N/A |
3.2 years (2-12) (minimum 24 months)a |
39/91 (42.9%) |
NR |
|
| 39 |
NR |
NR |
Revision patients |
NR |
NR |
NR |
|
| 33 |
NR |
NR |
>15% glenoid bone loss |
NR |
NR |
NR |
|
| 24 |
NR |
NR |
Collision/contact athletes |
NR |
NR |
NR |
|
Cautiero
(2017)[@140558] |
IV |
Modified Latarjet-Patte
(one screw and one washer) |
25 (26 shoulders) |
25.9 (18-46) |
46/50 (92%) |
Competitive contact sport |
53 months (3-6 years) |
NR |
25/50 (50.0%) <10; 20/50 (40.0%)10-12, 5/50 (10.0) >12 |
|
Elganainy
(2017)[@140641] |
IV |
Latarjet |
23 |
26.09 ±6.2 (18-41) |
20/23 (87.0%) |
N/A |
median 30 months ± 13.9 (17-58) |
6/23 (26.0%) |
NR |
|
Erşen
(2017 OTSR)[@140577] |
III |
Latarjet
(epilepsy vs. no epilepsy) |
9 (11 shoulders) |
31.3 |
42/62 (67.7%) |
Epilepsy |
|
|
|
|
| 53 (54 shoulders) |
31.2 |
|
No epilepsy |
|
|
|
|
Gough
(2017)[@140602] |
IV |
Latarjet |
48 (50 shoulders) |
27 (17-63) |
48/50 shoulders (96%) |
N/A |
clinical: 32 months (6-74) radiological: 20 months (2-74) |
NR |
8/50 (16%) |
|
Kee
(2017)[@140642] |
III |
Latarjet |
110 |
23.8 (14-52) |
100/110 (90.9%) |
N/A |
31 months (24-111) |
79/110 |
9.5 (3-20) |
|
Kordasiewicz
(2017)[@140643] |
III |
Latarjet
(open vs. arthroscopic) |
48 |
28 (18-59) |
45/48 (93.8%) |
N/A |
54.2 months |
0/48 (0.0%) |
5 (0-30) |
|
Marion
(2017)[@140567] |
II |
Mini-open Latarjet
(vs. arthroscopic Latarjet) |
20 |
27.3 ±7.5 |
16/22 (72.7%) |
N/A |
29.8 months ±4.4a (minimum 2 years) |
2/22 (9.1%) |
3.1 ± 3 |
|
Vadala
(2017)[@140644] |
IV |
Latarjet |
24 |
27.2 (18–46) |
22/24 (91.7%) |
Amateur sports/ Age ≤50 |
24 months |
NR |
11.8 |
|
Zhang
(2017)[@140645] |
III |
Bristow-Latarjet
(individualized coracoid osteotomy for 3D congruent arc glenoid reconstruction vs. classic Bristow-Latarjet) |
44 |
29.8 ± 11.9 |
38/44 (86.4%) |
Individualized coracoid osteotomy |
51.1 months ± 27.9 |
3/44 |
8.8 ± 3.8 |
|
| 34 |
29.3 ± 12.4 |
27/34 (79.4%) |
Classic Bristow-Latarjet |
50.9 months ± 28.9 |
2/34 |
9.0 ± 5.2 |
|
Beranger
(2016)[@140647] |
IV |
Bristow-Latarjet |
47 |
27.9 (18-45.7) |
46/47 (97.9%) |
Athletes <50 year |
46.8 ± 9.7 months |
NR |
NR |
|
Blonna
(2016)[@140648] |
III |
Bristow-Latarjet
(vs. Arthroscopic Bankart) |
30 |
31.5 (19-45) |
26/30 (86.7%) |
N/A |
5.3 years (2 to 8.7) |
0/30 (0.0%) |
19 (2->50) |
|
Chaudhary
(2016)[@140594] |
IV |
Mini-open Latarjet
(w/ arthrex wedge profile plate for graft fixation) |
24 |
31.8 (21–37) |
23/24 (95.8%) |
N/A |
26 months (24–30) |
24/24 |
7 (2–14) |
|
Cho
(2016)[@140611] |
III |
Latarjet
(vs. arthroscopic remplissage with Bankart repair) |
35 |
27.8 ± 7.9 (18-50) |
32/35 (91%) |
N/A |
30.4 months ± 11.2 (19–48) |
22/35 (62.8%) |
9.9 (2-100) |
|
Jamal
(2016)[@140649] |
IV |
Latarjet |
73 (77 shoulders) |
28 (20-50) |
70/73 (95.9%) |
N/A |
5.5 years (10 months-9 years) |
0/77 (0.0%) |
6 (5-14) |
|
Khater
(2016)[@140609] |
IV |
Latarjet |
73 (78 shoulders) |
26.8 (19-40) |
70/73 (96%) |
Patients w/ tramadol abuse |
28 months (24-35 months) |
10/73 (14%) |
14 (3-50) |
|
Li
(2016)[@140587] |
IV |
Latarjet |
25 |
55 ± 13 (26-79) |
7/25 (28.0%) |
Patients w/ chronic locked anterior shoulder dislocation |
31.6 months (24-107) |
0/25 (0%) |
NR |
|
Ropars
(2016)[@140651] |
IV |
Latarjet |
75 (77 shoulders) |
26.3 (17-48) |
54/77 (70.1%) |
N/A |
55 months (24-90) |
0/75 (0.0%) |
43/77 (55.8%) <5, 12/77 (15.6%) 5-10
22/77 (28.6%) >10, 51/77 (66.2%) subluxations |
|
Venkatachalam
(2016)[@140653] |
IV |
Sheffield Bone Block |
75 |
33 (16-45) |
59/75 (78.7%) |
N/A |
48 months (36 -84) |
75/75 |
NR |
|
Abelhady
(2015)[@140654] |
IV |
Latarjet
(congruent-arc Latarjet) |
13 (14 shoulders) |
24.4 (18–29) |
9/13 (69.2%) |
Patients w/ ≥20 recurrences |
33.64 months (24-45) |
0/13 (0%) |
Minimum 20 |
|
Arianjam
(2015)[@140655] |
IV |
Free Bone Graft
(absorbable nails, open Bankart repair of glenoid capsuloligamentous structures) |
34 |
21 (15-29) |
34/34 (100.0%) |
High risk athletes |
36 months (24-60) |
17/34 (50.0%) |
7/34 (20.6%) 1 dislocation, 12/34 (35.3%) 2-5 dislocations,
13/34 (38.2%) >5 dislocations |
|
Balestro
(2015)[@140560] |
IV |
Latarjet
(w/ resorbable screws) |
11 (12 shoulders) |
28.6 (16.6-43.3) |
7/11 (63.6%) |
N/A |
NR (minimum 2 years) |
NR |
NR |
|
Dos Santos
(2015)[@140656] |
III |
Latarjet-Patte
(vs. control group of volunteers asymptomatic for shoulder conditions and w/ demographics similar to study group) |
38 |
28.7 (17-41) |
26/38 (68.4%) |
N/A |
28.6 months (24-39 |
NR |
5.15 (2-14) |
|
Flinkkilä
(2015)[@140596] |
IV |
Latarjet |
49 |
28.4 (17–62) |
NR |
N/A |
38 months (24–85) |
52/52 (100.0%) |
NR |
|
Gordins
(2015)[@140588] |
IV |
Bristow-Latarjet |
31 |
27 (15-39) |
23/31 (74.2%) |
Patients w/ 33-35 years FU |
33-35 years |
11/31 (35.5%) |
NR |
|
Ikemoto
(2011)[@140590] |
IV |
Latarjet |
26 |
28 (17-47) |
26/26 100% |
N/A |
38 months (12-80 months) |
NR |
40 (2-100) |
|
Moon
(2015)[@140658] |
IV |
Latarjet |
44 |
24.5 ± 9.0 (14-52) |
41/44 (93.2%) |
N/A |
25.9 months ± 8.7 (20-32) |
22/44 (50%) |
7.7 (2-20) |
|
Ruci
(2015)[@140607] |
IV |
Bristow-Latarjet |
42 (45 shoulders) |
22 (95% CI, 18–42) (at time of first dislocation) |
40/42 (95.2%) |
N/A |
46 months (95% CI, 16-88) |
NR |
8 (95% CI, 0–18) |
|
Yang
(2016)[@140659] |
III |
Modified Latarjet
(≤25% glenoid bone loss vs. >25% glenoid bone loss) |
52 (54 shoulders) |
23.2 ± 7.42 |
41/52 (78.8%) |
N/A |
3.5 years (2-10) |
34/52 |
NR |
|
Zimmermann
(2016)[@140660] |
III |
Modified Latarjet
(vs. arthroscopic Bankart) |
93 |
30.8 ± 11.4a |
82/93 (88.2%) |
N/A |
119 months ± 23.2 |
0/93 (0%) |
NR |
|
Tasaki
(2015)[@140606] |
IV |
Bristow
(combined with arthroscopic Bankart repair) |
38 (40 shoulders) |
21 (17-25) |
37/38 (97.4%) |
Competitive rugby players |
30.5 months (24-42) |
8/40 (20.0%) |
NR |
|
Zhu
(2015)[@140554] |
IV |
Latarjet |
57 |
35.7 (18.4-57.4) |
45/63 (71.4%) |
N/A |
27.5 months (24.2-37.9) |
0/63 (0.0%) |
NR |
|
Bessière
(2014)[@140662] |
III |
Latarjet
(vs. Arthroscopic Bankart) |
93 |
26 (16–46) |
89/93 (95.7%) |
N/A |
72 months (50–118) |
0/93 (0.0%) |
34 (2-300) (dislocations or subluxations) |
|
Bouju
(2014)[@140664] |
IV |
Modified Latarjet-Patte
(associating "south-north" capsule retention w/ reinsertion to edge of glenoid cavity to coracoid bone-block) |
68 (70 shoulders) |
26.7 ± 8.4 |
48/68 (70.6%) |
N/A |
13 years (10–15) |
10/68 (14.7%) |
range 2-30 |
|
Mizuno
(2014)[@140665] |
IV |
Latarjet |
60 (68 shoulders) |
29.4 (16-58) |
49/60 (81.7%) 54/68 (79.4%) (shoulders) |
≥18 years follow-up |
20 years (18-22) |
0/68 (0%) |
NR |
|
Atalar
(2013)[@140601] |
IV |
Modified Latarjet |
35 |
35 (20-58) |
33/35 (94.3%) |
N/A |
24 months ± 12 (12-74) |
7/35 (20%) |
NR |
|
Bessière
(2013)[@140667] |
III |
Latarjet
(vs. Arthroscopic Bankart) |
51 |
25 (16-45) |
49/51 (96.1%) |
N/A |
66 months (50-80) |
0/51 (0.0%) |
22 (1-150) (episodes of instability) |
|
Di Giacomo
(2013)[@140668] |
IV |
Modified Latarjet
(use of a mini-plate developed by authors) |
26 |
31 ± 9 |
21/26 (80.8%) |
N/A |
26 months ± 3 |
0/26 (0%) |
6 ± 5.3 |
|
Holzer
(2013)[@140612] |
IV |
Latarjet-Patte |
148 |
28.4 ± 8.7 (16-57) |
106/148 (71.6%) |
N/A |
14.6 years (2.8-22.6) |
NR |
NR |
|
Lädermann
(2013)[@140614] |
IV |
Latarjet |
117 |
28.4 ± 8.5 (16-55) |
82/117 (70.1%) |
≥10 years follow-up |
16.2 years (10-22.2) |
0/117 (0.0%) |
NR |
|
Aydin
(2012)[@140632] |
IV |
Modified Bristow
(vs. open Bankart repair) |
13 |
29.6 (17-60)a |
34/38 (89.5%)a |
N/A |
5.5 years (35 months-9 years)a |
NR |
4-10 in 15 shoulders (39.5%), 10-20 in 10 shoulders (26.3%) > 20 in 13 shoulders (34.2%)a |
|
Cerciello
(2012)[@140584] |
IV |
Latarjet
(modifications: stable fixation with two malleolar screws and preserving the integrity of the fibers of the subscapularis tendon) |
26 (28 shoulders) |
Goalkeepers: 19 ± 2.8 (23–16)
General population: 21 ± 4.7 |
26/26 (100%) |
Soccer players |
85 months (5–180) |
NR |
7.5 (1–50) |
|
Neyton
(2012)[@140670] |
IV |
Laterjet-Patte |
34 (37 shoulders) |
23.4 (17-33) |
34/34 (100%) |
Rugby players |
12 years (68-237 months) |
0/34 (0%) |
NR |
|
Paladini
(2012)[@140671] |
III |
Bristow-Latarjet
(L-shape tenotomy vs. muscle split) |
376 |
27 ± 5 |
300/376 (79.8%) |
N/A |
45 months (42-48) |
NR |
NR |
|
Raiss
(2012)[@140579] |
IV |
Latarjet |
12 (14 shoulders) |
31 (23-55) |
10/12 (83.3%) |
Patients with epilepsy |
8.3 years (1-20) |
2/12 (16.7%) |
NR |
|
Schmid
(2012)[@140599] |
IV |
Latarjet |
49 |
29 (15-44) |
37/49 (75.5%) |
N/A |
38 months (23-63) |
49/49 (100.0%) |
NR |
|
Shah
(2012)[@140672] |
IV |
Latarjet
(patients w/ complications vs. patients w/out complications) |
47 (48 shoulders) |
30 (15-60) |
39/48 (81.3%) |
N/A |
In office: 9.4 months (6-55)
Final phone interview: (44/47 patients) 39.3 months (6-62) |
35/48 shoulders (72.9%) |
NR |
|
Emami
(2011)[@140673] |
IV |
Bristow-Latarjet |
30 |
30.56 (20–50) |
30/30 (100%) |
Non-athletes |
5 years (2–8) |
0/30 (0.0%) |
NR |
|
Hovelius
(2011)[@140675] |
III |
Bristow-Latarjet
(vs. Bankart) |
97 |
27.8 (17-51) |
82/97 (84.5%) |
N/A |
17 years (13-22)a |
5/97 (5.2%) |
NR |
|